Antineoplastic Combined Chemotherapy ProtocolsChemotherapy, AdjuvantDietary SupplementsCombined Modality TherapyAntineoplastic AgentsCisplatinTreatment OutcomeCyclophosphamideDoxorubicinNeoadjuvant TherapyDisease-Free SurvivalBreast NeoplasmsEtoposideNeoplasm StagingSurvival AnalysisDrug Administration SchedulePrognosisSurvival RateLung NeoplasmsMethotrexateCarboplatinPaclitaxelInduction ChemotherapyVinblastineNeoplasm Recurrence, LocalTaxoidsIfosfamideDrug Resistance, NeoplasmNeoplasmsBleomycinAntimetabolites, AntineoplasticDeoxycytidineOrganoplatinum CompoundsFollow-Up StudiesTime FactorsDouble-Blind MethodAnthracyclinesAntineoplastic Agents, AlkylatingChemotherapy, Cancer, Regional PerfusionCytarabineCarcinoma, Non-Small-Cell LungSalvage TherapyNeoplasm MetastasisOvarian NeoplasmsFood, FortifiedDose-Response Relationship, DrugVomitingTesticular NeoplasmsAdenocarcinomaNeutropeniaProspective StudiesTransplantation, AutologousNauseaLymphoma, Non-HodgkinRandom AllocationAntineoplastic Agents, PhytogenicColorectal NeoplasmsRadiotherapy, AdjuvantHodgkin DiseaseClinical Trials as TopicRadiotherapyAntibiotics, AntineoplasticVitaminsAnimal FeedRandomized Controlled Trials as TopicDacarbazineAdministration, OralNeoplasms, Germ Cell and EmbryonalCarmustineKaplan-Meier EstimateLomustineGranulocyte Colony-Stimulating FactorCamptothecinPlatinum CompoundsBrain NeoplasmsBone NeoplasmsInfusions, Intra-ArterialInfusions, IntravenousOsteosarcomaMelphalanLeukopeniaAntiemeticsMitomycinLiver NeoplasmsVitamin ETumor Markers, BiologicalThiotepaRecurrenceVitamin AHematopoietic Stem Cell TransplantationDrug TherapyPeritoneal NeoplasmsStomach NeoplasmsMitoxantroneCell Line, TumorLymphatic MetastasisTegafurFolic AcidPalliative CareAntibodies, Monoclonal, Humanized